Want to join the conversation?
$GS' revenue in Investment Management for 2Q16 fell by 18% to $1.35Bil from last year. The decline primarily reflected significantly lower incentive fees. In addition, management and other fees were slightly lower, on shifts in the mix of client assets and strategies, partially offset by impact of higher average assets under supervision.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?